Company Overview and News

54
Buy the FANG Stocks on Netflix-Related Weakness

16m investorplace
The unstoppable machine that is Netflix (NASDAQ:NFLX) finally hit a road-bump. The company added fewer subscribers than expected in the second quarter. That caused NFLX stock, which was up more than 100% year-to-date heading into the report, to drop in a big way.
FB SHOP AMZN GOOGL NFLX MSFT GOOG SNAP

9
Google Remains Strong After Antitrust Fine from EU

1h zacks
In recent news, Alphabet Inc. (GOOGL - Free Report) was hit by a record-breaking $5 billion fine by EU regulators for breaking antitrust laws. According to The New York Times, this steep antitrust penalty is among one of the most aggressive regulatory moves ever made against an American technology company. The fine comes from Google abusing its Android market dominance in three different areas. The three areas outlined include Google bundling its search engine and Chrome apps into the operating system; blocking phone makers from creating devices that run forked versions of Android; and paying large manufacturers to bundle the Google search app on handsets, according to The Verge.
FB SAP SAPGF GOOGL MSFT NYTAB GOOG INTC

3
Microsoft (MSFT) Slips 0.78% Ahead of Earnings: What To Watch

1h zacks
Microsoft (MSFT - Free Report) saw its stock price dip 0.78% to hit $105.12 per share Wednesday, just one day before the tech power is set to report its Q4 fiscal 2018 financial results. So let’s take a look at what investors should expect from Microsoft after the closing bell Thursday.
SAP SAPGF MSFT ORCL

21
Microsoft's focus on cloud, partnerships paying off - Channel NewsAsia

2h channelnewsasia
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp , a partnership that illustrates how Microsoft's chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE

9
Google’s Wrist-Slap May Echo For a While - Bloomberg

2h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG GOOG MS.PRA GS GLSSP MS JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI MS.PRI GOOGL GS.PRD MS.PRK GS.PRC MSFT GJS GS.PRN GS.PRK

21
Microsoft's focus on cloud, partnerships paying off

2h reuters
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp (MSFT.O), a partnership that illustrates how Microsoft’s chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE

39
Walmart Is Slowly Turning Into a Growth Company

3h investorplace
Last year, I was vocally bearish on traditional retail giant Walmart (NYSE:WMT). WMT stock was being awarded a growth multiple. But, the company was still growing at a rather anemic rate and was stuck in the low-growth brick-and-mortar retail market. As such, I felt a collapse in Walmart’s valuation and WMT stock was imminent.
AMZN NFLX MSFT WMT

59
Why Microsoft Stock Is Worth Buying Before Earnings

3h investorplace
In the National Football League, the last twenty yards before the goal line are known as the red zone. This is where some of the grittiest plays can occur. And it’s where the best teams know how to score and prove it over and over. And when you’re in the fourth quarter with the game on the line, being in this red zone is even more challenging.
GE GEC AMZN GOOGL CSCO GNE MSFT GOOG WMT

4
Is Apple About to Break Out Again?

3h zacks
Just a month and a half ago, we pondered whether Apple (AAPL - Free Report) would be the first company to get to a trillion dollars in market capitalization and concluded that it probably would, but that passing an arbitrary number didn’t matter all that much.
FB AAPL MSFT

1
Google's Eight Years of Antitrust Battles at the EU - Bloomberg

4h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MSFT

4
Microsoft Earnings Preview: Of Course, It’s All About the Cloud | InvestorPlace

4h investorplace
After the market closes on Thursday, Microsoft (NASDAQ:MSFT) will release its fourth-quarter earnings results. And for the most part, Wall Street is upbeat. In fact, during the past week, MSFT stock has logged a return of about 4.5%.
2454 GOOGL MSFT

5
Google Shrugs Off EU Fine; Damage to Hinge on Rivals' Next Moves - Bloomberg

5h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
GOOGL AAPL BC94 SMSN MSFT GOOG SMSD

7
Should You Buy Microsoft (MSFT) Stock Ahead of Q4 Earnings?

6h zacks
Shares of Microsoft (MSFT - Free Report) slipped in morning trading Wednesday, just one day before the company is set to report its Q4 and fiscal 2018 financial results. This might be a sign that investors are nervous about Microsoft ahead of its earnings release, but MSFT stock has still outpaced its industry and the S&P 500 since the start of the year.
GOOGL MSFT ORCL WMT

54
General Electric And Microsoft: A Match Made In Heaven

6h seekingalpha
General Electric and Microsoft announced an expanded agreement that has the potential to benefit both firms immensely.
GE GEC AMZN GOOGL GNE MSFT GOOG

12
Amazon.com's stock market value hits US$900 billion, threatens Apple

7h channelnewsasia
Amazon.com's stock market value reached US$900 billion on Wednesday for the first time, marking a major milestone in its 21-year trajectory as a publicly listed company and threatening to dislodge Apple as Wall Street's most valuable jewel.
WFM XOM MSFT

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to MSFT / Microsoft Corp. on message board site Silicon Investor.

Microsoft Corp. - Moderated (MSFT) Trend Setters and Range Riders
How high will Microsoft fly? Windows Phone
Microsoft: The Devices and Consumer Segment Windows 7
Windows 8 Microsoft - The u003cbu003eEvilu003c/bu003e empire
Microsoft (MSFT) Trash Talk Microsoft Windows 8: Migrating to Windows 8 Pro from Windows
CUSIP: 594918104